Billy Loo, MD, PhD, FASTRO

Billy W. Loo, Jr., M.D., Ph.D. is a Professor of Radiation Oncology at Stanford University. He is a physician-scientist Radiation Oncologist and Bioengineer, and Director of Thoracic Radiation Oncology at Stanford.

His clinical specialties are state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy. Dr. Loo is a recognized expert in thoracic cancers serving on the National Comprehensive Cancer Network (NCCN) Guidelines panels for thoracic malignancies.

His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. He also co-leads clinical trials of novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.

Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise radiation therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo's major laboratory research focus has been to co-lead a collaborative effort between the Stanford Cancer Institute and SLAC National Accelerator Laboratory to develop PHASER into a transformative yet clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH radiation therapy to optimize the biological therapeutic index.

Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none